Active non-specific immunotherapy of experimental tumours.
D000818:Animals; D001500:BCG Vaccine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000627:therapeutic use; D004195:Disease Models, Animal; D005936:Glucans / Q000627:therapeutic use; D006168:Guinea Pigs; D007167:Immunotherapy; D007978:Levamisole / Q000627:therapeutic use; D008114:Liver Neoplasms, Experimental / Q000628:therapy; D009374:Neoplasms, Experimental / Q000628:therapy*; D010586:Phagocytes / Q000187:drug effects; D011063:Poly A-U / Q000627:therapeutic use; D011425:Propionibacterium acnes / Q000276:immunology; D012330:RNA, Double-Stranded / Q000627:therapeutic use; D013297:Streptococcus pyogenes / Q000276:immunology
D001500:BCG Vaccine; D001428:Bacterial Vaccines; D005936:Glucans; D012330:RNA, Double-Stranded; D011063:Poly A-U; D007978:Levamisole